ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Last Bit of Nonsense By Weinberger; Magnuson May Write NCI Positions Into HEW Money Bill

July 18, 1975

NCI Advisory Groups To Be Cut By One-Third

April 22, 1977

Cooperative Group-cancer control Program To Continue

August 10, 1979

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

In Brief: Spitz elected President, ASPO: Karmanos Received $6 Million From Chrysler, Ford

May 30, 1997

Malpractice Reform Bill Introduced

July 28, 1989